Brachytherapy
Volume 5, Issue 1 , Pages 49-55 , January 2006

Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience

  • Elizabeth Falkenberg

      Affiliations

    • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    • ,
  • Robert Y. Kim

      Affiliations

    • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, University of Alabama at Birmingham, 130 TI, 1824 6th Avenue South, Birmingham, AL 35249. Tel.: +1-205-975-0222; fax: +1-205-975-0784.
    • ,
  • Sreelatha Meleth

      Affiliations

    • Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
    • ,
  • Jennifer De Los Santos

      Affiliations

    • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    • ,
  • Sharon Spencer

      Affiliations

    • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA

Received 9 December 2005 ,Revised 15 December 2005 ,Accepted 15 December 2005.

References 

  1. Cleaves MA. Radium therapy. Chic Med Rec. 1903;64:601
  2. Beth E, Eifel P, Moughan J, et al. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1966–1999): A Patterns of Care Study. Int J Radiat Oncol Biol Phys. 2005;63:1083–1092
  3. Henschke UK, Hilaris BS, Mahan DG. Remote afterloading with intracavitary applicators. Radiology. 1964;83:344–345
  4. O'Connell D, Howard N, Joslin CA, et al. A new remotely controlled unit for the treatment of uterine cancer. Lancet. 1965;18:570–571
  5. Joslin CA, Smith CW, Mallik A. The treatment of cervix cancer using high activity Cobalt60 sources. Br J Radiol. 1972;45:257–270
  6. Fu KK, Phillips TL. High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. [see comments] Int J Radiat Oncol Biol Phys. 1990;19:791–796
  7. Cikaric S. Radiation therapy of cervical carcinoma using either HDR or LDR afterloading: Comparison of 5-year results and complications. Strahlenther Onkol. 1988;82:119–122
  8. Shigematsu Y, Nishiyama K, Masaki N, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: A comparative study with a low-dose-rate system. Int J Radiat Oncol Biol Phys. 1983;9:351–356
  9. Inoue T, Hori S, Miyata Y, et al. High versus low dose rate intracavitary irradiation of carcinoma of the uterine cervix—A preliminary report. Acta Radiol Oncol. 1978;17:277–282
  10. Kucera H, Potter R, Knocke TH, et al. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer. Wien Klin Wochenschr. 2001;113:58–62
  11. Teshima T, Inoue T, Ikeda H, et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital. Cancer. 1993;72:2409–2414
  12. Patel FD, Sharma SC, Negi PS, et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial. Int J Radiat Oncol Biol Phys. 1994;28:335–341
  13. Hareyama M, Sakata K, Oouchi A, et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: A randomized trial. Cancer. 2002;94:117–124
  14. Lertsanguansinchai P, Lertbutasayanukul C, Shotelersuk K, et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1424–1431
  15. Nag S, Erickson B, Thomadsen B, et al. For the American Brachytherapy Society. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–211
  16. Petereit DG, Sardaria JN, Potter DM, et al. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer analysis of tumor recurrence—The University of Wisconsin. Int J Radiat Oncol Biol Phys. 1999;45:1267–1274
  17. Dulcos M, Souhami L, Corns R, et al. Cervical cancer: Timing of high-dose rate brachytherapy with external beam radiotherapy. Radiother Oncol. 2001;58:514
  18. Chao KSC, Williamson JF, Grigsby PW, et al. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1998;40:397–403
  19. Larciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A Patterns-of-Care study. Int J Radiat Oncol Biol Phys. 1993;25:391–398
  20. Fyles A, Kene TJ, Barton M, et al. The effect of treatment in the local control of cervix cancer. Radiother Oncol. 1992;25:273–279
  21. Perez CA, Grigsby PW, Castro-Vita H, et al. Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;32:1275–1288
  22. Chen S, Liang J, Yang S, et al. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol. 2003;67:69–76
  23. Hama Y, Uematsu M, Nagata I, et al. Carcinoma of the uterine cervix: Twice- versus once-weekly high-dose-rate brachytherapy. Radiology. 2001;219:207–212
  24. Ogino I, Kitamura T, Okamoto N, et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys. 1995;31:725–734
  25. Ferrigno R, Novaes PERDS, Pellizzon ACA, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys. 2001;50:1123–1135
  26. Clark BG, Souhami L, Roman TN, et al. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1997;38:989–993
  27. Chen MS, Lin FJ, Hong CH, et al. High-dose-rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan. Int J Radiat Oncol Biol Phys. 1991;20:915–919
  28. Schoeppel SL, LaVigne ML, Martel MK, et al. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implication for dose specification. Int J Radiat Oncol Biol Phys. 1994;28:277–283
  29. Briot E, Crevoisier D, Petrow P, et al. Dose–volume histogram analysis for tumor and critical organs in intracavitary brachytherapy of cervical cancer with the use of MRI. (Abstr.) Radiother Oncol. 2001;60:S3
  30. Fellner C, Potter R, Knocke TH, et al. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with special attention to some quality assurance aspects. Radiother Oncol. 2001;58:53–62
  31. Okawa I, Sakata S, Kita-Okawa M. Comparison of HDR versus LDR regimens for intracavitary brachytherapy of cervical cancer: Japanese experience. In:  Mould RF editors. International brachytherapy. Veenendaal, The Netherlands: Nucletron B.V.; 1992;p. 13–17
  32. Orton CG, Seyedsadr M, Somnay A. Comparisons of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 1991;21:1425–1434
  33. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule?. Int J Radiat Oncol Biol Phys. 1999;43:359–366
  34. Toita T, Kakinohana Y, Ogawa K, et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys. 2003;56:1344–1353
  35. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with, and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966–972
  36. Sood B, Gorla G, Grupta S, et al. Two fractions of high-dose rate brachytherapy in the management of cervix cancer: Clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys. 2002;53:702–706
  37. Barrillot I, Horiot JC, Pegneaux J, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: French cooperative study: Update and multi-variate analysis of prognostic factor. Int J Radiat Oncol Biol Phys. 1997;38:969–978
  38. Eifel PJ, Morris M, Wharton JT, et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1994;29:9–16
  39. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 1992;69:2796–2806
  40. Hsu HC, Leung SW, Huang EY, et al. Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1998;40:405–410
  41. Ito H, Kutuki S, Nishiguchi I, et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy—Correlation between tumor size and failure. Radiother Oncol. 1994;31:240–247
  42. Kim RY, Caranto JF, Tucker JC. Image-based intracavitary brachytherapy in cancer of the cervix: Analysis of CT-based tumor coverage by pear-shaped isodose dimensions. (Abstr.) Int J Radiat Oncol Biol Phys. 1997;39:299
  43. Kim RY, Spencer SA. Tumor shrinkage before intracavitary brachytherapy for cancer of the cervix: Radiotherapy alone versus concurrent chemo-radiotherapy. Cancer J. 2000;6:377–380
  44. Lee CM, Shrieve DC, Gaffney DK. Rapid involution and mobility of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2004;58:625–630
  45. Dinniwell R, Chan P, Milosevic M, et al. Assessment of radiotherapy response using magnetic resonance imaging tumor volumetry in carcinoma of the uterine cervix. Radiat Oncol. 2004;72:S58
  46. Hong JH, Chen MS, Lin FJ, et al. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 1992;22:913–917
  47. Mayr NA, Yuh W, Zheng J, et al. Tumor size evaluated by pelvic examination compared with 3-D MR quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys. 1997;39:395–404
  48. Mizoe J. Analysis of the dose–volume histogram in uterine cervical cancer of diagnostic CT. Strahlenther Onkol. 1990;166:279–284
  49. Terahara A, Nakano T, Ischikawa A, et al. Dose–volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer. Int J Radiat Oncol Biol Phys. 1996;35:549–554
  50. Suyama S, Nakaguchi T, Kawakami K, et al. Computed tomography analysis of causes of local failure in radiotherapy for cervical carcinoma. Cancer. 1998;83:1956–1965
  51. Gerstner N, Wachter S, Reinstadler E, et al. Radiography compared to sectional image (CT/MR) based 3D treatment planning in cervix cancer brachytherapy: Results of a perspective comparative trial. (Abstr.) Radiother Oncol. 2001;60:S3
  52. Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: Analysis of dose–volume histograms. Brachytherapy. 2003;2:200–206

• Note: Presented at the annual meeting of the American Society for Therapeutic and Radiation Oncology, in Salt Lake City, UT in October 2003.

PII: S1538-4721(05)00199-6

doi: 10.1016/j.brachy.2005.12.001

Brachytherapy
Volume 5, Issue 1 , Pages 49-55 , January 2006

Article Tools

* Image Usage & Resolution